Today: 2 May 2026

PetMed Express (PETS) Stock: $4 Takeover Proposal Sparks Surge — News, Forecasts, and Key Risks on Dec. 12, 2025

PetMed Express (PETS) Stock: $4 Takeover Proposal Sparks Surge — News, Forecasts, and Key Risks on Dec. 12, 2025

PetMed Express shares surged 68% to close at $2.98 Thursday after confirming an unsolicited, non-binding $4-per-share cash buyout proposal from Singapore’s SilverCape Investments. Trading volume topped 105 million shares, far above average. SilverCape disclosed its offer in an SEC filing and owns about 12% of PetMed. The board is reviewing the bid; no shareholder action is required yet.
12 December 2025
··
AppLovin Stock (NASDAQ: APP) News, Forecasts and Analyst Targets — What’s Driving Shares on Dec. 12, 2025

AppLovin Stock (NASDAQ: APP) News, Forecasts and Analyst Targets — What’s Driving Shares on Dec. 12, 2025

AppLovin shares traded near $714.50 in early extended trading Dec. 12 after closing at $716.98, close to their 12-month high of $745.61. Jefferies raised its price target to $860, while Benchmark set a new target at $775. Recent SEC filings show CIBC Asset Management, Metavasi Capital, and Quantinno Capital Management increased their positions. Institutional ownership stands at 41.85%, according to MarketBeat.
12 December 2025
·
Costco Stock (COST) Today: Earnings Beat, Membership Momentum, Tariff Lawsuit Headlines, and Fresh Wall Street Forecasts (Dec. 12, 2025)

Costco Stock (COST) Today: Earnings Beat, Membership Momentum, Tariff Lawsuit Headlines, and Fresh Wall Street Forecasts (Dec. 12, 2025)

Costco reported Q1 fiscal 2026 earnings of $4.50 per share and total revenue of $67.3 billion, beating analyst estimates. Net sales rose 8.2% to $66 billion, with membership fees up to $1.33 billion. Shares dipped slightly after hours despite the beat, as investors weighed the stock’s high valuation. Comparable sales climbed 6.4%, led by 9% adjusted growth in Canada.
12 December 2025
··
JPMorgan Chase Stock (JPM) on Dec. 12, 2025: Price Near a 52‑Week High as 2026 Expense Outlook, Dividend and Analyst Targets Drive the Forecast

JPMorgan Chase Stock (JPM) on Dec. 12, 2025: Price Near a 52‑Week High as 2026 Expense Outlook, Dividend and Analyst Targets Drive the Forecast

JPMorgan Chase shares closed at $317.38 on Dec. 12, near record highs after rebounding from a sharp drop earlier in the week. The stock fell 4.3% after management projected 2026 expenses could reach $105 billion, surpassing analyst estimates. Trading volume spiked as investors reacted to the new guidance. The 52-week high stands at $322.25, set in November.
12 December 2025
·
Costco Stock (COST) Outlook on Dec. 12, 2025: Earnings Beat, Analyst Price Targets, Tariff Risks, and What Comes Next

Costco Stock (COST) Outlook on Dec. 12, 2025: Earnings Beat, Analyst Price Targets, Tariff Risks, and What Comes Next

Costco reported fiscal Q1 net sales of $65.98 billion, up 8.2% year over year, and net income of $2 billion, or $4.50 per share, beating estimates. Comparable sales rose 6.4%, with U.S. comps up 5.9%. Despite the beat, investor reaction was muted amid concerns over valuation and macroeconomic uncertainty. Record food-court and bakery volume highlighted strong holiday demand.
12 December 2025
··
Rezolute (RZLT) Stock Update Dec. 12, 2025: Phase 3 sunRIZE Miss Sparks Selloff, Analysts Reset Targets, and 2026 Catalysts

Rezolute (RZLT) Stock Update Dec. 12, 2025: Phase 3 sunRIZE Miss Sparks Selloff, Analysts Reset Targets, and 2026 Catalysts

Rezolute shares plunged 87% to around $1.40 on December 12, 2025, after its Phase 3 sunRIZE trial for ersodetug in congenital hyperinsulinism failed to meet primary or key secondary endpoints. The trial enrolled 63 patients; efficacy differences versus placebo were not statistically significant. Two serious hypersensitivity reactions were reported. Rezolute plans to meet with the FDA under Breakthrough Therapy Designation.
12 December 2025
Strategy Inc (MSTR) Stock News Today: Nasdaq 100 Reshuffle Risk, MSCI Index Fight, and Wall Street Forecasts (Dec. 12, 2025)

Strategy Inc (MSTR) Stock News Today: Nasdaq 100 Reshuffle Risk, MSCI Index Fight, and Wall Street Forecasts (Dec. 12, 2025)

Strategy Inc (NASDAQ: MSTR) traded at $183.30 midday Friday as investors watched for a possible removal from the Nasdaq 100, with an announcement expected after the close. Analysts estimate exclusion could trigger $1.6 billion in passive fund outflows. MSCI is also considering a rule that could bar firms with large Bitcoin holdings from its indexes. Strategy has publicly opposed the proposal.
12 December 2025
·
Paranovus Entertainment Technology Ltd (PAVS) Stock: Latest News, SEC Filings, Earnings Takeaways, and Forecasts for December 12, 2025

Paranovus Entertainment Technology Ltd (PAVS) Stock: Latest News, SEC Filings, Earnings Takeaways, and Forecasts for December 12, 2025

Paranovus Entertainment Technology Ltd. (NASDAQ: PAVS) traded around $0.03–$0.04 on December 12, 2025, with sharp swings in pre-market and extended hours. The company reported $12.41 million in revenue for the six months ended September 30, but filings show mixed profitability. Investors are watching a $200 million shelf registration and a Nasdaq bid-price compliance deadline on January 7, 2026.
12 December 2025
··
Eli Lilly Stock (NYSE: LLY) in Focus: Retatrutide’s Near-30% Weight-Loss Data, FDA Fast-Track Questions for Orforglipron, and Fresh Analyst Forecasts (Dec. 12, 2025)

Eli Lilly Stock (NYSE: LLY) in Focus: Retatrutide’s Near-30% Weight-Loss Data, FDA Fast-Track Questions for Orforglipron, and Fresh Analyst Forecasts (Dec. 12, 2025)

Eli Lilly shares traded near $1,009 Friday after its obesity drug retatrutide showed 28.7% average weight loss in a Phase 3 trial, though with notable discontinuation rates. Reuters reported FDA leaders pushed to speed review of Lilly’s oral GLP-1 drug orforglipron, raising internal concerns. The company is building a $6 billion Alabama plant to boost manufacturing. Analyst price targets remain supportive but vary widely.
12 December 2025
··
AMD Stock News Today (Dec. 12, 2025): AI “Bubble” Jitters Hit Chipmakers as Analysts Keep a Bullish Tilt on Advanced Micro Devices (NASDAQ: AMD)

AMD Stock News Today (Dec. 12, 2025): AI “Bubble” Jitters Hit Chipmakers as Analysts Keep a Bullish Tilt on Advanced Micro Devices (NASDAQ: AMD)

AMD shares traded near $221.43 on Dec. 12, 2025, slipping alongside Nvidia as Broadcom’s margin warning and Oracle’s spending outlook rattled AI-linked stocks. Sector sentiment, not company news, drove moves as investors questioned AI profitability after recent capital spending shocks. Time’s “Person of the Year” feature on AMD CEO Lisa Su added to chatter about market sentiment.
12 December 2025
····
Palantir Stock (PLTR) News Today: Navy ShipOS Deal, Lawsuit Escalation, and 2026 Forecasts (Dec. 12, 2025)

Palantir Stock (PLTR) News Today: Navy ShipOS Deal, Lawsuit Escalation, and 2026 Forecasts (Dec. 12, 2025)

Palantir shares traded between $180.21 and $188.50 on Dec. 12, with market cap near $447 billion after a year-to-date gain of about 140%. The company expanded its lawsuit against AI startup Percepta, naming several former employees. Palantir also secured a U.S. Navy “ShipOS” contract worth up to $448 million.
12 December 2025
····
Meta (META) Stock News Today: Analyst Targets, AI Spending Debate and 2026 Outlook (Dec. 12, 2025)

Meta (META) Stock News Today: Analyst Targets, AI Spending Debate and 2026 Outlook (Dec. 12, 2025)

Meta Platforms shares traded at $647.66 pre-market Friday, down from $652.71 at the prior close and well below the $796.25 52-week high. Investors are reacting to renewed concerns over AI spending after Oracle’s warning, a Morgan Stanley price target cut to $750, and technical signals pointing to weaker momentum. Analyst sentiment remains broadly positive despite volatility.
12 December 2025
···
Aurora Cannabis (ACB) Stock Jumps on US Marijuana Rescheduling Headlines: Today’s News, Forecasts, and Analysis (Dec. 12, 2025)

Aurora Cannabis (ACB) Stock Jumps on US Marijuana Rescheduling Headlines: Today’s News, Forecasts, and Analysis (Dec. 12, 2025)

Aurora Cannabis (ACB) jumped about 15% in pre-market trading Friday after reports that President Trump may direct agencies to reclassify marijuana as a Schedule III drug. The White House said no final decisions have been made. Investors responded to the potential for eased penalties and tax burdens. Aurora closed at $4.55 on Dec. 11 and was indicated near $5.30 early Friday.
12 December 2025
Alphabet (GOOG) Stock Today: Google Class C Shares Face AI Rival Pressure, New Antitrust Risks, and a Waymo Recall — What Investors Are Watching (Dec. 12, 2025)

Alphabet (GOOG) Stock Today: Google Class C Shares Face AI Rival Pressure, New Antitrust Risks, and a Waymo Recall — What Investors Are Watching (Dec. 12, 2025)

Alphabet’s Class C stock (GOOG) closed at $313.70 on Dec. 11 after volatile trading and was modestly higher in premarket action Dec. 12. Investors are reacting to OpenAI’s GPT‑5.2 launch and Disney partnership, EU regulatory threats, and a U.S. Waymo recall. Market focus remains on AI competition and scrutiny of Alphabet’s AI spending returns.
12 December 2025
··
1 … 1,230 1,231 1,232 1,233 1,234 … 1,889

Stock Market Today

  • 3 Vanguard ETFs to Safeguard Portfolios Against Stock Market Crash
    May 2, 2026, 9:04 AM EDT. Despite the S&P 500 hitting record highs, signs of economic strain are evident, including a slowing labor market, rising inflation up to 3.3% in March, and geopolitical tensions from the Iran conflict. These factors threaten a swift market downturn. High exposure to tech stocks, especially in S&P 500-based portfolios (over 30% concentration), increases risk in such environments. Vanguard offers three ETFs that may cushion portfolios in a crash: the High Dividend Yield ETF (VYM), emphasizing established, cash-generative companies; the Health Care ETF (VHT), focusing on recession-resistant healthcare firms; and the Short-Term TIPS ETF, which invests in Treasury Inflation-Protected Securities to hedge against inflation. These funds provide diversification and defensive positioning amid growing uncertainty.

Latest article

Beyond ChatGPT And Nvidia: 3 Technologies Wall Street May Have To Reprice Before 2026 Ends

Beyond ChatGPT And Nvidia: 3 Technologies Wall Street May Have To Reprice Before 2026 Ends

2 May 2026
The S&P 500 and Nasdaq closed at record highs Friday as Alphabet, Amazon, Meta, and Microsoft projected 2026 AI spending above $700 billion. Meta shares dropped nearly 10% after raising its capital-spending outlook, while Alphabet rose on strong Google Cloud revenue. Meta acquired Assured Robot Intelligence, expanding into robotics AI. Google began selling its AI chips directly to customers, challenging Nvidia.
Forget Big Tech: Data Storage Stocks Are Becoming AI’s Quiet Market Dark Horse

Forget Big Tech: Data Storage Stocks Are Becoming AI’s Quiet Market Dark Horse

2 May 2026
Seagate shares rose 7.9% and Sandisk jumped 8.3% Friday, while Western Digital slipped 0.6%. Sandisk reported Q3 revenue up 251% to $5.95 billion and signed $42 billion in long-term supply deals. Western Digital’s Q3 revenue climbed 45% to $3.34 billion, topping analyst estimates. Seagate forecast Q4 revenue of $3.45 billion, citing AI-driven demand.
Go toTop